Wide QRS Complex and Lateral ST-T Segment Abnormality Are Associated With Worse Clinical Outcomes in COVID-19 Patients.


Journal

The American journal of the medical sciences
ISSN: 1538-2990
Titre abrégé: Am J Med Sci
Pays: United States
ID NLM: 0370506

Informations de publication

Date de publication:
05 2021
Historique:
received: 18 08 2020
revised: 13 10 2020
accepted: 11 12 2020
pubmed: 15 2 2021
medline: 1 6 2021
entrez: 14 2 2021
Statut: ppublish

Résumé

The information on electrocardiographic features of patients with coronavirus disease 2019 (COVID-19) is limited. Our aim was to determine if baseline electrocardiographic features of hospitalized COVID-19 patients are associated with markers of myocardial injury and clinical outcomes. In this retrospective, single center cohort study, we included 223 hospitalized patients with laboratory-confirmed COVID-19. Clinical, electrocardiographic and laboratory data were collected and analyzed. Primary composite endpoint of mortality, need for invasive mechanical ventilation, or admission to the intensive care unit was assessed. Forty patients (17.9%) reached the primary composite endpoint. Patients with the primary composite endpoint were more likely to have wide QRS complex (>120 ms) and lateral ST-T segment abnormality. The multivariable Cox regression showed increasing odds of the primary composite endpoint associated with acute respiratory distress syndrome (odds ratio 7.76, 95% CI 2.67-22.59; p < 0.001), acute cardiac injury (odds ratio 3.14, 95% CI 1.26-7.99; p = 0.016), high flow oxygen therapy (odds ratio 2.43, 95% CI 1.05-5.62; p = 0.037) and QRS duration longer than >120 ms (odds ratio 3.62, 95% CI 1.39-9.380; p = 0.008) Patients with a wide QRS complex (>120 ms) had significantly higher median level of troponin T and pro-BNP than those without it. Patients with abnormality of lateral ST-T segment had significantly higher median level of troponin T and pro-BNP than patients without. The presence of QRS duration longer than 120 ms and lateral ST-T segment abnormality were associated with worse clinical outcomes and higher levels of myocardial injury biomarkers.

Sections du résumé

BACKGROUND
The information on electrocardiographic features of patients with coronavirus disease 2019 (COVID-19) is limited. Our aim was to determine if baseline electrocardiographic features of hospitalized COVID-19 patients are associated with markers of myocardial injury and clinical outcomes.
METHODS
In this retrospective, single center cohort study, we included 223 hospitalized patients with laboratory-confirmed COVID-19. Clinical, electrocardiographic and laboratory data were collected and analyzed. Primary composite endpoint of mortality, need for invasive mechanical ventilation, or admission to the intensive care unit was assessed.
RESULTS
Forty patients (17.9%) reached the primary composite endpoint. Patients with the primary composite endpoint were more likely to have wide QRS complex (>120 ms) and lateral ST-T segment abnormality. The multivariable Cox regression showed increasing odds of the primary composite endpoint associated with acute respiratory distress syndrome (odds ratio 7.76, 95% CI 2.67-22.59; p < 0.001), acute cardiac injury (odds ratio 3.14, 95% CI 1.26-7.99; p = 0.016), high flow oxygen therapy (odds ratio 2.43, 95% CI 1.05-5.62; p = 0.037) and QRS duration longer than >120 ms (odds ratio 3.62, 95% CI 1.39-9.380; p = 0.008) Patients with a wide QRS complex (>120 ms) had significantly higher median level of troponin T and pro-BNP than those without it. Patients with abnormality of lateral ST-T segment had significantly higher median level of troponin T and pro-BNP than patients without.
CONCLUSIONS
The presence of QRS duration longer than 120 ms and lateral ST-T segment abnormality were associated with worse clinical outcomes and higher levels of myocardial injury biomarkers.

Identifiants

pubmed: 33581838
pii: S0002-9629(20)30549-8
doi: 10.1016/j.amjms.2020.12.012
pmc: PMC7834457
pii:
doi:

Substances chimiques

Biomarkers 0
Troponin T 0
Natriuretic Peptide, Brain 114471-18-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

591-597

Informations de copyright

Copyright © 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Références

Eur J Heart Fail. 2011 Apr;13(4):398-405
pubmed: 21239404
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Card Fail. 2020 Jul;26(7):626-632
pubmed: 32544622
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Eur Heart J Qual Care Clin Outcomes. 2020 Jul 1;6(3):204-207
pubmed: 32348472
Ann Saudi Med. 2016 Jan-Feb;36(1):78-80
pubmed: 26922692
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Life Sci. 2020 Jul 15;253:117723
pubmed: 32360126
Eur J Heart Fail. 2020 May;22(5):911-915
pubmed: 32275347
J Card Fail. 2020 Jun;26(6):470-475
pubmed: 32315733
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
Crit Pathw Cardiol. 2021 Mar 1;20(1):44-52
pubmed: 32467423
J Am Coll Cardiol. 2009 Mar 17;53(11):976-81
pubmed: 19281930

Auteurs

Mehmet Rasih Sonsoz (MR)

Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey. Electronic address: mrsonsoz@gmail.com.

Aytac Oncul (A)

Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

Erdem Cevik (E)

Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

Huseyin Orta (H)

Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

Mustafa Yilmaz (M)

Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

Elif Ayduk Govdeli (E)

Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

Asli Nalbant (A)

Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

Zeynep Gizem Demirtakan (ZG)

Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

Mirac Tonyali (M)

Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

Damla Durmus (D)

Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

Ilkay Anakli (I)

Department of Intensive Care Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Ozlem Polat (O)

Department of Intensive Care Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Yunus Catma (Y)

Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Naci Senkal (N)

Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Alpay Medetalibeyoglu (A)

Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Murat Kose (M)

Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Samim Emet (S)

Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

Tufan Tukek (T)

Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH